BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 28560678)

  • 1. Clinical Relevance of a Candidate Stem Cell Marker, p75 Neurotrophin Receptor (p75NTR) Expression in Circulating Tumor Cells.
    Okumura T; Yamaguchi T; Watanabe T; Nagata T; Shimada Y
    Adv Exp Med Biol; 2017; 994():247-254. PubMed ID: 28560678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of circulating tumor cells by p75NTR expression in patients with esophageal cancer.
    Yamaguchi T; Okumura T; Hirano K; Watanabe T; Nagata T; Shimada Y; Tsukada K
    World J Surg Oncol; 2016 Feb; 14(1):40. PubMed ID: 26897248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow Cytometric Detection of Circulating Tumor Cells Using a Candidate Stem Cell Marker, p75 Neurotrophin Receptor (p75NTR).
    Okumura T; Yamaguchi T; Watanabe T; Nagata T; Shimada Y
    Methods Mol Biol; 2017; 1634():211-217. PubMed ID: 28819854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced cancer stem cell properties of a mitotically quiescent subpopulation of p75NTR-positive cells in esophageal squamous cell carcinoma.
    Kojima H; Okumura T; Yamaguchi T; Miwa T; Shimada Y; Nagata T
    Int J Oncol; 2017 Jul; 51(1):49-62. PubMed ID: 28534989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p75 neurotrophin receptor expression is a characteristic of the mitotically quiescent cancer stem cell population present in esophageal squamous cell carcinoma.
    Yamaguchi T; Okumura T; Hirano K; Watanabe T; Nagata T; Shimada Y; Tsukada K
    Int J Oncol; 2016 May; 48(5):1943-54. PubMed ID: 26984177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream® in patients with breast cancer treated with primary systemic therapy.
    Le Du F; Fujii T; Kida K; Davis DW; Park M; Liu DD; Wu W; Chavez-MacGregor M; Barcenas CH; Valero V; Tripathy D; Reuben JM; Ueno NT
    PLoS One; 2020; 15(3):e0229903. PubMed ID: 32214335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The biological role of the low-affinity p75 neurotrophin receptor in esophageal squamous cell carcinoma.
    Okumura T; Tsunoda S; Mori Y; Ito T; Kikuchi K; Wang TC; Yasumoto S; Shimada Y
    Clin Cancer Res; 2006 Sep; 12(17):5096-103. PubMed ID: 16951226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p75 neurotrophin receptor: A potential surface marker of tongue squamous cell carcinoma stem cells.
    Tong D; Sun J; Huang P; Li M; Zhang F
    Mol Med Rep; 2017 May; 15(5):2521-2529. PubMed ID: 28447720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating tumor cells detected using fluid-assisted separation technique in esophageal squamous cell carcinoma.
    Choi MK; Kim GH; I H; Park SJ; Lee MW; Lee BE; Park DY; Cho YK
    J Gastroenterol Hepatol; 2019 Mar; 34(3):552-560. PubMed ID: 30426559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancer.
    Hyun KA; Koo GB; Han H; Sohn J; Choi W; Kim SI; Jung HI; Kim YS
    Oncotarget; 2016 Apr; 7(17):24677-87. PubMed ID: 27013581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer.
    Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL
    Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal-Epithelial Transition and Circulating Tumor Cells in Small Cell Lung Cancer.
    Hamilton G; Rath B
    Adv Exp Med Biol; 2017; 994():229-245. PubMed ID: 28560677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-renewal and chemotherapy resistance of p75NTR positive cells in esophageal squamous cell carcinomas.
    Huang SD; Yuan Y; Liu XH; Gong DJ; Bai CG; Wang F; Luo JH; Xu ZY
    BMC Cancer; 2009 Jan; 9():9. PubMed ID: 19134212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.
    Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM
    World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of Circulating Tumor Cells by Fluorescent Immunohistochemistry in Patients with Esophageal Squamous Cell Carcinoma: Potential Clinical Applications.
    Li SP; Guan QL; Zhao D; Pei GJ; Su HX; Du LN; He JX; Liu ZC
    Med Sci Monit; 2016 May; 22():1654-62. PubMed ID: 27184872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of carcinoembryonic antigen-, cytokeratin 19-, or survivin-positive circulating tumor cells in the peripheral blood of esophageal squamous cell carcinoma patients treated with radiotherapy.
    Yin XD; Yuan X; Xue JJ; Wang R; Zhang ZR; Tong JD
    Dis Esophagus; 2012; 25(8):750-6. PubMed ID: 22394149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Context-dependent adaption of EpCAM expression in early systemic esophageal cancer.
    Driemel C; Kremling H; Schumacher S; Will D; Wolters J; Lindenlauf N; Mack B; Baldus SA; Hoya V; Pietsch JM; Panagiotidou P; Raba K; Vay C; Vallböhmer D; Harréus U; Knoefel WT; Stoecklein NH; Gires O
    Oncogene; 2014 Oct; 33(41):4904-15. PubMed ID: 24141784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research.
    Grover PK; Cummins AG; Price TJ; Roberts-Thomson IC; Hardingham JE
    Ann Oncol; 2014 Aug; 25(8):1506-16. PubMed ID: 24651410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A microchip filter device incorporating slit arrays and 3-D flow for detection of circulating tumor cells using CAV1-EpCAM conjugated microbeads.
    Kim YJ; Koo GB; Lee JY; Moon HS; Kim DG; Lee DG; Lee JY; Oh JH; Park JM; Kim MS; Woo HG; Kim SI; Kang P; Choi W; Sim TS; Park WY; Lee JG; Kim YS
    Biomaterials; 2014 Aug; 35(26):7501-10. PubMed ID: 24917030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulatory Tumor Cells in Esophageal Adenocarcinoma.
    Gopalan V; Lam AK
    Methods Mol Biol; 2018; 1756():177-186. PubMed ID: 29600370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.